Flipkart Achieves RecordBreaking SingleDay Sales of 200 Million on Ecommerce Giants Largest Shopping Event Amazon Expands AI Shopping Platform to Retail Partners Signs Kate Spade as First Customer Analysts Highlight 7 Stocks for Exceptional Earnings Growth Potential Solar Stock Reaches Key Technical Level Monolithic Power Systems Outperforms Broadly as Wall Street Weighs Growth Potential Bitcoin Dips Below 76K as Geopolitical Risks and ETF Outflows Weigh on Sentiment Inflation Pressures Broaden Beyond Energy Shelter and Services Costs Reaccelerate Two Harbors Investments Corp TWOD Q1 2026 Earnings EPS Surges Past Estimates in Resilient Quarter SAN Q1 2026 Earnings EPS Beats Estimates by 31 Shares Rally Capstone Holding Corp CAPS Q4 2025 Earnings Massive EPS Miss Amidst Operational Challenges SBCF Q1 2026 Earnings EPS Beats Estimates Amid Stable Operations Valero Energy Q1 2026 Earnings Strong Refining Margins Drive 32 EPS Beat Despite Weaker Stock Reaction eXoZymes Inc EXOZ Climbs 313 as Biotech Stock Tests Key Resistance at 1074 Polaryx Therapeutics PLYX Slips 271 as Stock Tests Key Support Near 238 BXP Inc BXP Holds Steady Near Support as Trading Activity Remains Subdued Pitney Bowes Faces Resistance as Selling Pressure Intensifies Structure Therapeutics GPCR Edges Higher on Modest Gains Testing Key Resistance Levels Musical and Theatre Stars on Chasing Dreams How Acting As If Could Reshape Financial Futures Arm Holdings Q1 2026 Earnings EPS Beat Drives Positive Market Reaction DT Cloud Star Acquisition Units DTSQU Hold Steady at 1095 as SPAC Waits for Catalyst AIRG Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction SII Q1 2026 Earnings Earnings Beat Amid Precious Metals Tailwinds Stock Edges Lower IIPR Q1 2026 Earnings EPS Misses Estimates Amid Persistent Cannabis Sector Headwinds HTHT Q1 2026 Earnings Slight EPS Miss Amidst Modest Stock Decline SRE Q1 2026 Earnings Slight EPS Miss Amid Solid Operational Performance and Positive Market Reaction ACU Q1 2026 Earnings EPS Misses Estimates by 505 as Stock Edges Higher CGON Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment